Resonance Specialties Limited (BOM:524218)
101.80
-2.80 (-2.68%)
At close: Feb 12, 2026
Resonance Specialties Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 899.72 | 778.07 | 553.01 | 588.15 | 757.57 | 702.88 |
Other Revenue | - | - | - | - | - | 6.08 |
| 899.72 | 778.07 | 553.01 | 588.15 | 757.57 | 708.95 | |
Revenue Growth (YoY) | 28.60% | 40.70% | -5.97% | -22.36% | 6.86% | 23.75% |
Cost of Revenue | 590.78 | 495.33 | 356.28 | 334.69 | 446.69 | 442.54 |
Gross Profit | 308.94 | 282.73 | 196.73 | 253.46 | 310.88 | 266.41 |
Selling, General & Admin | 57.19 | 50.73 | 48.21 | 43.41 | 43.2 | 40.39 |
Other Operating Expenses | 123.31 | 124.2 | 100.38 | 141.83 | 100.17 | 77.4 |
Operating Expenses | 191.5 | 190.51 | 163.16 | 200 | 160.88 | 127.64 |
Operating Income | 117.43 | 92.22 | 33.57 | 53.46 | 150 | 138.78 |
Interest Expense | -2.8 | -3.48 | -3.27 | -0.33 | -0.15 | -1.38 |
Interest & Investment Income | 3.18 | 3.18 | 5.22 | 8.21 | 7.14 | 1.5 |
Currency Exchange Gain (Loss) | 3.86 | 3.86 | 3.84 | 7.04 | 4.31 | 6.72 |
Other Non Operating Income (Expenses) | 0.23 | 0.05 | 0.07 | 0.07 | 0.73 | -1.5 |
EBT Excluding Unusual Items | 121.9 | 95.82 | 39.43 | 68.44 | 162.03 | 144.11 |
Gain (Loss) on Sale of Investments | 2.72 | 2.72 | 0.1 | 0.01 | 0.74 | 1.54 |
Gain (Loss) on Sale of Assets | -1.85 | -1.85 | 0.1 | 0.06 | 0.03 | - |
Other Unusual Items | -0.18 | -7.91 | - | - | 0.08 | - |
Pretax Income | 122.6 | 88.78 | 39.64 | 68.51 | 162.87 | 145.65 |
Income Tax Expense | 34.02 | 23.12 | 9.95 | 18.5 | 39.27 | 40.41 |
Net Income | 88.58 | 65.66 | 29.68 | 50.01 | 123.6 | 105.24 |
Net Income to Common | 88.58 | 65.66 | 29.68 | 50.01 | 123.6 | 105.24 |
Net Income Growth | 112.00% | 121.20% | -40.65% | -59.54% | 17.44% | 91.08% |
Shares Outstanding (Basic) | 11 | 12 | 12 | 12 | 12 | 12 |
Shares Outstanding (Diluted) | 11 | 12 | 12 | 12 | 12 | 12 |
Shares Change (YoY) | -0.46% | - | - | - | - | - |
EPS (Basic) | 7.71 | 5.69 | 2.57 | 4.33 | 10.71 | 9.12 |
EPS (Diluted) | 7.71 | 5.69 | 2.57 | 4.33 | 10.71 | 9.12 |
EPS Growth | 112.99% | 121.20% | -40.65% | -59.54% | 17.44% | 91.08% |
Free Cash Flow | - | -40.7 | -2.54 | -159.73 | 127.12 | 34.35 |
Free Cash Flow Per Share | - | -3.53 | -0.22 | -13.84 | 11.01 | 2.98 |
Dividend Per Share | - | 1.000 | - | 1.000 | 1.000 | 1.000 |
Gross Margin | 34.34% | 36.34% | 35.57% | 43.09% | 41.04% | 37.58% |
Operating Margin | 13.05% | 11.85% | 6.07% | 9.09% | 19.80% | 19.57% |
Profit Margin | 9.84% | 8.44% | 5.37% | 8.50% | 16.31% | 14.85% |
Free Cash Flow Margin | - | -5.23% | -0.46% | -27.16% | 16.78% | 4.84% |
EBITDA | 131.9 | 106.23 | 46.99 | 67.03 | 165.99 | 147.41 |
EBITDA Margin | 14.66% | 13.65% | 8.50% | 11.40% | 21.91% | 20.79% |
D&A For EBITDA | 14.46 | 14.01 | 13.42 | 13.58 | 15.99 | 8.64 |
EBIT | 117.43 | 92.22 | 33.57 | 53.46 | 150 | 138.78 |
EBIT Margin | 13.05% | 11.85% | 6.07% | 9.09% | 19.80% | 19.57% |
Effective Tax Rate | 27.75% | 26.04% | 25.11% | 27.00% | 24.11% | 27.74% |
Revenue as Reported | 909.71 | 787.87 | 562.34 | 604.27 | 771.06 | 718.73 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.